.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Cipla
Julphar
Boehringer Ingelheim
Johnson and Johnson
Deloitte
McKinsey
AstraZeneca
Accenture
Mallinckrodt

Generated: November 24, 2017

DrugPatentWatch Database Preview

FRAGMIN Drug Profile

« Back to Dashboard

What is the patent landscape for Fragmin, and what generic Fragmin alternatives are available?

Fragmin is a drug marketed by Pfizer Inc and is included in one NDA.

The generic ingredient in FRAGMIN is dalteparin sodium. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dalteparin sodium profile page.

Pharmacology for FRAGMIN

Medical Subject Heading (MeSH) Categories for FRAGMIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;INJECTION020287-008Apr 4, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-009May 1, 2007RXYesNo► Subscribe► Subscribe► Subscribe
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-005Apr 4, 2002RXYesNo► Subscribe► Subscribe► Subscribe
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-010May 1, 2007RXYesNo► Subscribe► Subscribe► Subscribe
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-001Dec 22, 1994RXYesNo► Subscribe► Subscribe► Subscribe
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-003Mar 18, 1996RXYesNo► Subscribe► Subscribe► Subscribe
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-004Jan 30, 1998RXYesNo► Subscribe► Subscribe► Subscribe
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-002May 1, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-006Apr 4, 2002RXYesYes► Subscribe► Subscribe► Subscribe
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-007Apr 4, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: FRAGMIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-001Dec 22, 1994► Subscribe► Subscribe
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-004Jan 30, 1998► Subscribe► Subscribe
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-003Mar 18, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Federal Trade Commission
Julphar
Cantor Fitzgerald
Chubb
Merck
UBS
QuintilesIMS
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot